Why the study?
There have been no previous reported cases of pericarditis secondary to endoscopic cyanoacrylate injection into the pericardium.
Direct endoscopic cyanoacrylate injection into the pericardial space is a rare complication of gastric variceal treatment that causes persistent foreign-body pericarditis requiring prolonged anti-inflammatory therapy and serial multimodality imaging monitoring.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to pericarditis risk after endoscopic cyanoacrylate injection; leaves open incidence, prevention, and management strategies.
BACKGROUND: Endoscopic cyanoacrylate injection (ECI) is a standard management for bleeding gastric varices. There have been no previous cases of pericarditis secondary to ECI into the pericardium. CASE SUMMARY: A 55-year-old woman with bleeding gastric varices secondary to pancreatic neuroendocrine tumor with splenic vein involvement underwent ECI, which resulted in postprocedural pericarditis secondary to direct injection into the pericardial space. DISCUSSION: Management of this foreign substance-induced pericarditis is outside the realm of current guidelines. Based on the known inflammatory and insoluble nature of cyanoacrylate, standard anti-inflammatory therapies were implemented. Despite prolonged anti-inflammatory therapy, this patient continues to have symptomatic pericarditis as well as inflammatory changes on cardiac imaging months after her procedure. TAKE-HOME MESSAGES: Postprocedural pericarditis from ECI is an infrequent yet serious complication. It is imperative to monitor serial inflammatory markers and cardiac imaging, as well as to monitor symptom resolution, to assess the need for prolonged anti-inflammatory tapers or pericardiectomy.
No takes yet. Share an insight, caveat, or question.
Hagan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: